A clinical evaluation of serum concentrations of intercellular adhesion molecule-1 in patients with gastric cancer

Table 1 Correlation between soluble ICAM-1 concentrations and clinical histopathology in gastric cancer

Factors	n	ICAM-1 (x-±s, μg/L)	Positive rate % (n)
Tumor size
≥ 5 cm	19	406.7 ± 90.2a	73.3 (14/19)
< 5 cm	15	319.9 ± 105.3	40.0 (6/15)
Lymph node invasion
Positive	21	403.6 ± 99.7a	71.4 (15/21)
Negative	13	302.7 ± 81.4	38.5 (5/13)
Grade of differentiation
Differentiated	12	320.5 ± 93.2	33.3 (4/12)
Poorly differentiated	22	393.9 ± 103.1	72.7 (16/22)
Clinical staging
I-II	11	306.0 ± 82.3	36.4 (4/11)
III-IV	23	397.1 ± 102.4b	69.6 (16/23)

^aP < 0.01,

^bP < 0.05, vs the control.